ReviewInternational journal of environmental research and public health2022
Asbestos and Other Hazardous Fibrous Minerals: Potential Exposure Pathways and Associated Health Risks.
Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.
- Examining the Environmental Ramifications of Asbestos Fiber Movement Through the Water-Soil Continuum: A Review.International journal of environmental research and public health · 2025Pooled it
- Asbestos-Related Respiratory Diseases in Spain: Insights From the Spanish Registry.American journal of industrial medicine · 2026Observational
- Naturally occurring asbestos and its possible environmental and health implications in the Basilicata region (Southern Italy).Environmental geochemistry and health · 2026Article
- Article
- Impact of intercostal nerve cryoablation on opioid use in pleural mesothelioma surgery: results from a high-volume integrated regional center.Journal of thoracic disease · 2026Article
- Asbestos Poverty as a New Paradigm for Multidimensional Urban Sustainability.Journal of urban health : bulletin of the New York Academy of Medicine · 2026Article
- Distinct comorbidity profiles and outcomes in asbestosis versus idiopathic pulmonary fibrosis: a 6-year prospective cohort study.BMC pulmonary medicine · 2026Article
- Invisible threats: environmental asbestos exposure and water contamination in a former mining area of Northeastern Brazil.Cadernos de saude publica · 2026Article
- The psychological impact of asbestos exposure: risk perception and emotional distress among former workers in Tuscany.BMC public health · 2025Article
- Environmental and occupational exposure to erionite and related health risks: progress and prospects.Annals of work exposures and health · 2025Review
- Mesothelioma Incidence Rates in Australia since 1982: Exploring Age, Period, and Cohort Effects and Future Projections.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025Article
- ExpoPath: A method for identifying and annotating exposure pathways from chemical co-occurrence networks.The Science of the total environment · 2025Article
- Mosses in Urban Environments as Passive Biofilters and Organisms Impacted by Asbestos-Contaminated Habitats.International journal of environmental research and public health · 2025Review
- Assessing trends and burden of occupational exposure to asbestos in the United States: a comprehensive analysis from 1990 to 2019.BMC public health · 2024Article
- Telomere length andRadiology and oncology · 2024Observational
- Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant mesothelioma.Oncoscience · 2024Article
- Clinical investigation of former workers exposed to asbestos: the health surveillance experience of an Italian University Hospital.Frontiers in public health · 2024Article
- Influence of Varying Concentrations of Epoxy, Rice Husk, AlPolymers · 2023Article
- Waterborne asbestos: Good practices for surface waters analyses.Frontiers in chemistry · 2023Article
- The incidence of malignancies in asbestosis with chrysotile exposure: a large Chinese prospective cohort study.Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 3 countries.
Funding
Abstract
There are six elongate mineral particles (EMPs) corresponding to specific dimensional and morphological criteria, known as asbestos. Responsible for health issues including asbestosis, and malignant mesothelioma, asbestos has been well researched. Despite this, significant exposure continues to occur throughout the world, potentially affecting 125 million people in the workplace and causing thousands of deaths annually from exposure in homes. However, there are other EMPS, such as fibrous/asbestiform erionite, that are classified as carcinogens and have been linked to cancers in areas where it has been incorporated into local building materials or released into the environment through earthmoving activities. Erionite is a more potent carcinogen than asbestos but as it is seldom used for commercial purposes, exposure pathways have been less well studied. Despite the apparent similarities between asbestos and fibrous erionite, their health risks and exposure pathways are quite different. This article examines the hazards presented by EMPs with a particular focus on fibrous erionite. It includes a discussion of the global locations of erionite and similar hazardous minerals, a comparison of the multiple exposure pathways for asbestos and fibrous erionite, a brief discussion of the confusing nomenclature associated with EMPs, and considerations of increasing global mesothelioma cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.